The evidence leans constructive5 supporting, 2 against, 1 worth knowing
Supporting
trading 24% above its 200-day average
up 84% over twelve months
matches beating the market for 6 months, which has beaten the market by +0.50 points over 20 sessions across 60,366 past signals
3 independent kinds of evidence agree today, which is uncommon
revenue grew 264% year on year in the quarter ending 30 June 2026
Against
1 of the scans it matches has historically underperformed the market
net margin has narrowed from 9.2% to -10.5% across four quarters
Worth knowing
the 50-day and 200-day averages disagree, which usually means a turn in progress rather than a trend to lean on
What would change this read: a close below 6,477, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
from the filings and from the price, with the figure behind every line
Working3
Revenue rose 263.6% year on year, from Rs 82 cr to Rs 299 cr.
+263.6%Rs 82 crRs 299 cr
Trading 23.7% above its 200-day average, which is the line most investors use to separate a bull phase from a bear one.
+23.7%
Up 84.0% over the past year.
+84.0%
Needs watching4
Net profit -1924.5% year on year, Rs 2 cr to Rs -31 cr.
-1924.5%Rs 2 crRs -31 cr
Profit growth was -1924.5%, while revenue growth was +263.6%, indicating profit grew slower than revenue.
-1924.5%+263.6%
Net margin fell from 2.1% to -10.5%.
2.1%-10.5%
Down over three months despite being up on the year.
-14.1% 3M+84.0% 1Y
Every figure here is computed — from the company’s own filings, or from its own closing prices. Wording of 3 of these 4 filing lines was drafted by a language model, which is given the figures and may not introduce another — any sentence containing a number that did not come from the filings is discarded before it reaches this page.
How it has performed
price return over each window, beside the median NSE stock over the same days
What the scans say today
3 of 47 matched on 10 Sep
COCKERILL matches 3 of the 47 scans today, across 3 different kinds of evidence. Three or more independent families agreeing is uncommon — it is the same test the shortlist on every page uses.
COCKERILL trades at 215× trailing earnings, below its median of 237× over this window — 10% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
Order win filings were typically -0.10pt vs the market over the next 5 sessions (n=630) · Analyst call filings were typically +0.11pt vs the market over the next 5 sessions (n=4,339) · Other filing filings were typically +0.01pt vs the market over the next 5 sessions (n=17,202)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
revenue grew 264% against the same quarter a year earlier
revenue rose in 3 of the last 4 quarters
Going against it
profit dropped 1925% year on year
net margin narrowed from 2.1% to -10.5%
the company has not been profitable over the last four filed quarters
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
30 Jun · consolidated
299
-33
-31
—
-10.5%
Q4 FY26
31 Mar · consolidated
345
6
7
14.91
2.1%
Q3 FY26
31 Dec · standalone
102
-2
0
0.86
0.4%
Q2 FY26
30 Sep · standalone
97
12
9
18.06
9.2%
Q1 FY26
30 Jun · standalone
82
2
2
3.48
2.1%
Q4 FY25
31 Mar · standalone
76
-1
-1
—
-1.0%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-8.4%
Versus 200-day average+23.7%
Below 52-week high-22.2%
Above 52-week low+96.2%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)44.1
Higher closes in last 52 of 5
Six-month return+65.97%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)3.25%
Volume versus 20-day0.3x
Median daily turnoverRs 5.4 cr
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.
Session
Scans
Which
10 Sep
1
Profit falling while the price holds up
9 Sep
1
Profit falling while the price holds up
8 Sep
1
Profit falling while the price holds up
7 Sep
2
MACD just turned positive, Profit falling while the price holds up
4 Sep
1
Profit falling while the price holds up
3 Sep
1
Profit falling while the price holds up
2 Sep
2
Oversold, but trend intact, Profit falling while the price holds up
1 Sep
1
Profit falling while the price holds up
31 Aug
1
Profit falling while the price holds up
28 Aug
1
Profit falling while the price holds up
27 Aug
1
Profit falling while the price holds up
26 Aug
2
Gapped up and held it, Profit falling while the price holds up